/ Print /

Mari Edlin
Mari Edlin is a frequent contributor to Managed Healthcare Executive. She is based in Sonoma, California.
Autoimmune drug pipeline: What health execs should watch
New drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Five imitation-worthy palliative care programs
Here's how five health plans are successfully approaching palliative care.
Prevent polypharmacy problems
Polypharmacy presents real problems—especially for older adults.
New strategies for managing drug spend: RA, Cancer, Hep C
New strategies for managing drug spend: RA, Cancer, Hep C
The proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areas
Find out about the latest treatment and drug pipeline developments
Top pharmacy challenges of 2017
Top pharmacy challenges of 2017
High drug prices continue to plague payers, but various contributing factors intensify the problem.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costs
Plans and PBMs are finding new ways to rein in pharmacy costs.
Online drug pricing tools that influence consumers
Online drug pricing tools that influence consumers
Consumers are demanding transparency in the prices of drugs. Here’s how they are getting it.
Three ways technology is improving the pharmaceutical industry
Technology in pharmacy is leading to improved safety, accountability, and efficiency.
Specialty pharmaceuticals: Solving top challenges
Specialty pharmaceuticals: Solving top challenges
Managed Healthcare Executive recently invited a panel of experts representing different sectors of the healthcare industry to explore specialty pharmaceutical challenges and identify potential solutions.